查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565716

全身麻醉药物市场，按类型、给药途径、手术类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

General Anesthesia Drugs Market, By Type, By Route Of Administration, By Surgery Type, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年全身麻醉药物市场规模预估为51.142亿美元，2024年至2032年复合年增长率为4.00%。

全身麻醉药品市场-市场动态

微创手术 (MIS) 治疗慢性疾病的频率不断增加

慢性病盛行率的上升正在推动 MIS 全身麻醉药物的成长。对慢性病手术治疗的需求增加，直接导致寻求手术的患者数量增加，从而推动了对安全有效麻醉药物的需求增加。 MIS 技术的采用增加，通常会缩短復健时间并缩短住院时间，是医​​疗保健提供者增加使用的重要驱动力。这一趋势鼓励开发和采用先进的全身麻醉药物，以提高患者在手术过程中的舒适度和安全性，最终有助于市场的扩大，以满足对高效手术解决方案不断增长的需求。例如，《微创外科杂誌》（MIS期刊）发表的一篇文章称，微创外科（MIS）领域的论文被接受并发表了58篇，其中包括37篇综述、10篇原创文章和一篇系统综述。这项系统研究针对经导管主动脉瓣植入手术的连合对齐进行电脑辅助品质评估，这可能是缓解肝细胞癌冠状动脉再通和重做经导管主动脉瓣植入(TAVI) 的新领域。

全身麻醉药物市场 - 关键见解

我们的研究分析师估计，从 2024 年到 2032 年，全球市场将以 4.00% 的复合年增长率发展。

2023 年，根据类型细分，异丙酚产业拥有最高的市场份额。

根据给药途径细分，静脉注射 (IV) 给药途径细分市场在 2023 年占据主导地位。

根据手术类型细分，预计膝关节和髋关节置换术领域将在预测期内引领市场。

从地区来看，2023 年，北美地区的收入最高。

全身麻醉药物市场-細項分析：

全球车载聚光灯市场分为五类：类型、给药途径、手术类型、最终用户和地区。

市场依类型分为四个部分：异丙酚、地氟烷、七氟烷和其他。 2023年，异丙酚类别主导市场，预计在预测期内将以最快的复合年增长率成长。异丙酚以其快速起效和恢復时间而闻名，可提高患者舒适度和手术效率。它经常用于麻醉诱导和维持，为各种外科和诊断操作提供了适应性强的选择。该药物良好的药物动力学特征，包括半衰期短和代谢快，增加了它对麻醉科医师的吸引力。

市面上依给药途径分为两种：吸入型和静脉注射型。静脉注射 (IV) 行业的收入份额最高。这种成长趋势主要是由许多重要变数推动的，包括静脉麻醉剂传递、功效和便利性的进步。静脉麻醉因其起效快、给药控制精确而受到青睐，这对于处理复杂的外科手术和保障病人安全至关重要。即时修改剂量的能力使麻醉师能够根据患者的需求和手术要求量身订做麻醉深度。

全身麻醉药物市场 - 地理洞察

从地理来看，该市场包括北美、亚太地区、中东以及非洲、拉丁美洲、欧洲。这些区域根据哪些国家带来业务进一步划分。

受一系列关键变数的推动，例如慢性病的高盛行率、技术进步和重要的医疗基础设施，北美全身麻醉药品市场将在 2023 年占据主导地位。心血管疾病和癌症等慢性疾病的发生率增加，经常需要进行外科手术，这增加了全身麻醉的需求。

由于医疗保健成本上升、手术需求增加以及技术进步，人口不断增长，亚太地区全身麻醉药品市场正在迅速扩大。亚太地区人口众多且多样化，慢性病发生率不断上升以及外科手术的需求增加，都导致全身麻醉的需求增加。中国和印度政府正在大力投资医疗基础设施和医疗技术，这正在推动市场成长。

全身麻醉药品市场-竞争格局：

全身麻醉药品市场的特点是由几个主要参与者组成，包括辉瑞公司、Paion AG、B. Braun Melsungen 和Avet Pharmaceuticals Inc. 等老牌製药公司，这些公司凭藉庞大的产品线和顺畅的分销渠道占据市场主导地位。这些企业也加大了研发投入。在小型公司和仿製药製造商争夺市场份额的过程中，低成本版本也越来越受到重视。在对安全、有效麻醉的需求不断增加的情况下，随着公司努力增强其产品供应实力并扩大其市场影响力，战略联盟、合併和收购如雨后春笋般涌现。

最新进展：

2024 年 4 月，百特增加了在美国的药品供应，推出了盐酸罗哌卡因注射液 (USP)。这种新药采用方便、即用型、单剂量输液袋包装。

目录

第 1 章：全身麻醉药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的全身麻醉药物市场片段
    • 依给药途径分類的全身麻醉药物市场片段
    • 按手术类型分類的全身麻醉药物市场片段
    • 最终使用者的全身麻醉药物市场片段
    • 按国家/地区分類的全身麻醉药物市场片段
    • 按地区分類的全身麻醉药物市场片段
  • 竞争洞察

第 3 章：全身麻醉药物主要市场趋势

  • 全身麻醉药物市场驱动因素
    • 市场驱动因素的影响分析
  • 全身麻醉药品市场限制
    • 市场限制影响分析
  • 全身麻醉药物市场机会
  • 全身麻醉药物市场未来趋势

第 4 章：全身麻醉药品产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：全身麻醉药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：全身麻醉药物市场格局

  • 2023 年全身麻醉药物市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：全身麻醉药物市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 异丙酚
    • 地氟烷
    • 七氟醚
    • 其他的

第 8 章：全身麻醉药物市场 - 依给药途径

  • 概述
    • 按管理途径分類的细分市场占有率分析
    • 吸入
    • 静脉

第 9 章：全身麻醉药物市场 - 依手术类型

  • 概述
    • 按手术类型分類的细分市场份额分析
    • 膝关节和髋关节置换术
    • 癌症手术
    • 心臟手术
    • 一般外科

第 10 章：全身麻醉药物市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 门诊手术中心
    • 医院

第 11 章：全身麻醉药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美全身麻醉药物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按手术类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲全身麻醉药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按手术类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区全身麻醉药物主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模与预测（依手术类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲全身麻醉药物主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按手术类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲全身麻醉药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（依手术类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 全身麻醉药品产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Paion AG
    • B. Braun Melsungen
    • Avet Pharmaceuticals Inc
    • Baxter International Inc.
    • Abbott Laboratories
    • Fresenius SE and Co. KGaA
    • Abbvie Inc,
    • AstraZeneca plc
    • Hikma Pharmaceuticals plc
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3920

REPORT HIGHLIGHT

General Anesthesia Drugs market size was evaluated at USD 5,114.2 million in 2023, rising at a CAGR of 4.00% from 2024 to 2032.

General anesthetic drugs are essential for establishing and maintaining a state of unconsciousness without pain during a variety of surgical operations. These medications, which are delivered intravenously or via inhalation, are utilized in a variety of surgeries, including cardiac, orthopedic, oncology, and gastrointestinal procedures.

General Anesthesia Drugs Market- Market Dynamics

Increasing Frequency of Chronic Illnesses Treated with Minimally Invasive Surgery (MIS)

Higher prevalence rates of chronic diseases are driving the growth of MIS general anesthesia drugs. A greater demand for surgical treatment in chronic diseases translates directly into a higher number of patients seeking surgery, thus fueling increased demand for safe and effective anesthesia drugs. Increased adoption of MIS techniques, which often result in quicker recovery times and shorter hospital stays, are an important driver of increased use by healthcare providers. This trend encourages the development and adoption of advanced general anesthesia drugs that enhance patient comfort and safety during procedures, ultimately contributing to the expansion of the market in response to the growing demand for efficient surgical solutions. For instance, an article published in the Minimal Invasive Surgery Journal (MIS journal) stated that 58 papers on minimal invasive surgery (MIS) were accepted and published, including 37 reviews, 10 original articles, and one systematic review. The systematic study addressed computer-assisted quality evaluation for surgeries commissural alignment in transcatheter aortic valve implantation, which may be a new frontier to ease coronary re-access and redo transcatheter aortic valve implantation (TAVI) in hepatocellular carcinoma.

General Anesthesia Drugs Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of 4.00% from 2024 to 2032.

In 2023, the propofol sector had the highest market share based on Type segmentation.

Based on Route Of Administration segmentation, The intravenous (IV) Route Of Administration segment dominated the market in 2023.

The knee and hip replacement sector is expected to lead the market over the projection period, according to Surgery Type segmentation.

On the basis of region, in 2023, North America generated the highest revenue.

General Anesthesia Drugs Market- Segmentation Analysis:

The global vehicle-mounted spotlights market is divided into five categories: Type, Route Of Administration, Surgery Type, End-user, and region.

The market is classified into four segments based on the type: Propofol, Desflurane, Sevoflurane, and Others. In 2023, the propofol category dominated the market and is predicted to grow at the quickest CAGR over the forecast period. Propofol is known for its rapid onset and recovery times, which improve patient comfort and procedural efficiency. It is frequently used for anesthesia induction and maintenance, giving it an adaptable option for a wide range of surgical and diagnostic operations. The agent's good pharmacokinetic profile, which includes a short half-life and quick metabolism, adds to its appeal among anesthesiologists.

The market is separated into two types based on the route of administration: inhalation and intravenous. The intravenous (IV) sector had the highest revenue share. This growing trend is primarily driven by a number of significant variables, including advances in IV anesthetic delivery, efficacy, and convenience. IV anesthesia is favored because of its quick onset of effect and precise control over drug administration, which are critical for handling complex surgical operations and guaranteeing patient safety. The ability to modify dosage in real time enables anesthesiologists to tailor anesthetic depth based on the patient's demands and the surgical requirements.

General Anesthesia Drugs Market- Geographical Insights

Geographically, this market encompasses North America, Asia Pacific, the Middle East, and Africa, Latin America, Europe. These zones are further split based on which countries bring business.

The North American general anesthesia medicines market dominated in 2023, driven by a number of crucial variables, such as the high prevalence of chronic diseases, technological improvements, and significant healthcare infrastructure. The increased frequency of chronic illnesses such as CVD and cancer, which frequently necessitate surgical procedures, increases the demand for general anesthesia.

The Asia Pacific general anesthetic medicines market is quickly expanding as a result of rising healthcare costs, a growing population with increased surgical needs, and technological improvements. The large and diverse population of APAC, as well as the rising frequency of chronic illnesses and the requirement for surgical operations, all contribute to increased need for general anesthesia. Governments in China and India are investing heavily in healthcare infrastructure and medical technology, which is driving market growth.

General Anesthesia Drugs Market- Competitive Landscape:

The general anesthesia drugs market is characterized by a few main players, including established pharmaceutical companies such as Pfizer Inc., Paion AG, B. Braun Melsungen, and Avet Pharmaceuticals Inc., which dominate the market with a massive product line and smooth distribution channels. These players have also increased their investments in R&D. Low-cost versions are also gaining prominence in the quest for market share by smaller firms and generic manufacturers. Strategic alliances, mergers, and acquisitions mushroom as companies strive to build strength in their product offerings and increase their reach into the marketplace at a time when demand for safe, effective anesthesia is ever-increasing.

Recent Developments:

In April 2024, Baxter increased their pharmaceutical offering in the United States with the introduction of Ropivacaine Hydrochloride Injection, USP. This new medicine is packaged in a convenient, ready-to-use, single-dose infusion bag.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERAL ANESTHESIA DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Paion AG
  • B. Braun Melsungen
  • Avet Pharmaceuticals Inc
  • Baxter International Inc.
  • Abbott Laboratories
  • Fresenius SE and Co. KGaA
  • Abbvie Inc,
  • AstraZeneca plc
  • Hikma Pharmaceuticals plc
  • Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Propofol
  • Desflurane
  • Sevoflurane
  • Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Inhalation
  • Intravenous

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY SURGERY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Knee and hip replacements
  • Cancer surgery
  • Heart surgeries
  • General surgery

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Ambulatory surgical centers
  • Hospital

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. General Anesthesia Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. General Anesthesia Drugs Market Snippet by Type
    • 2.1.2. General Anesthesia Drugs Market Snippet by Route Of Administration
    • 2.1.3. General Anesthesia Drugs Market Snippet by Surgery Type
    • 2.1.4. General Anesthesia Drugs Market Snippet by End-user
    • 2.1.5. General Anesthesia Drugs Market Snippet by Country
    • 2.1.6. General Anesthesia Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. General Anesthesia Drugs Key Market Trends

  • 3.1. General Anesthesia Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. General Anesthesia Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. General Anesthesia Drugs Market Opportunities
  • 3.4. General Anesthesia Drugs Market Future Trends

4. General Anesthesia Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. General Anesthesia Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. General Anesthesia Drugs Market Landscape

  • 6.1. General Anesthesia Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. General Anesthesia Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Propofol
    • 7.1.3. Desflurane
    • 7.1.4. Sevoflurane
    • 7.1.5. Others

8. General Anesthesia Drugs Market - By Route Of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route Of Administration, 2023 & 2032 (%)
    • 8.1.2. Inhalation
    • 8.1.3. Intravenous

9. General Anesthesia Drugs Market - By Surgery Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Surgery Type, 2023 & 2032 (%)
    • 9.1.2. Knee and hip replacements
    • 9.1.3. Cancer surgery
    • 9.1.4. Heart surgeries
    • 9.1.5. General surgery

10. General Anesthesia Drugs Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 10.1.2. Ambulatory surgical centers
    • 10.1.3. Hospital

11. General Anesthesia Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. General Anesthesia Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. General Anesthesia Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. General Anesthesia Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. General Anesthesia Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. General Anesthesia Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- General Anesthesia Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Paion AG
    • 12.2.3. B. Braun Melsungen
    • 12.2.4. Avet Pharmaceuticals Inc
    • 12.2.5. Baxter International Inc.
    • 12.2.6. Abbott Laboratories
    • 12.2.7. Fresenius SE and Co. KGaA
    • 12.2.8. Abbvie Inc,
    • 12.2.9. AstraZeneca plc
    • 12.2.10. Hikma Pharmaceuticals plc
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us